Rchr
J-GLOBAL ID:201801000607178400   Update date: Apr. 24, 2024

Koyasu Sho

Koyasu Sho
Research field  (2): Radiology ,  Tumor biology
Research theme for competitive and other funds  (9):
  • 2022 - 2025 網羅的遺伝子スクリーニング技術を用いた甲状腺癌内用療法に対する抵抗性因子の探索
  • 2020 - 2023 Exploration of Companion Diagnosis and Personalized Medicine of Tumor Using Chemokine Receptor Imaging
  • 2019 - 2022 Development of Nuclear Medicine Imaging Techniques for Personalized Medicine Focusing on Metabolic Changes in Glioblastoma
  • 2018 - 2021 Mechanism of Action and Function of a novel HIF-1 activator in p53-deficient cancers
  • 2017 - 2020 癌細胞の低酸素応答と放射線抵抗性を担う新規遺伝子の機能解析と治療・画像化への展開
Show all
Papers (78):
  • Sho Koyasu, Akihiko Sugimoto, Junichi Matsubara, Manabu Muto, Yuji Nakamoto. SMARCA4-Deficient Poorly Differentiated Adenocarcinoma of the Gallbladder. Clinical Nuclear Medicine. 2024
  • Toshiya Takamura, Sho Koyasu, Akihiko Sugimoto, Takayuki Yamamoto, Yuji Nakamoto. Hyalinizing Clear Cell Carcinoma in the Sphenoid Sinus. Clinical nuclear medicine. 2024. 49. 3. 287-288
  • Hiroki Tanaka, Sho Koyasu, Masahiro Kikuchi, Mami Iima, Koichi Omori, Yuji Nakamoto. Utility of Diffusion-weighted MR Imaging for Evaluating the Depth of Invasion in Oral Tongue Squamous Cell Carcinoma. Magnetic Resonance in Medical Sciences. 2024
  • Yukari SHIRAI, Tatsuya SUWA, Minoru KOBAYASHI, Sho KOYASU, Hiroshi HARADA. DDX5 enhances HIF-1 activity by promoting the interaction of HIF-1α with HIF-1β and recruiting the resulting heterodimer to its target gene loci. Biology of the Cell. 2023
  • Eitaro Kidera, Sho Koyasu, Kenji Hirata, Masatsugu Hamaji, Ryusuke Nakamoto, Yuji Nakamoto. Convolutional neural network-based program to predict lymph node metastasis of non-small cell lung cancer using 18F-FDG PET. Annals of nuclear medicine. 2023
more...
MISC (36):
more...
Awards (15):
  • 2024/01 - 北米放射線学会 Editor’s Recognition Award for Reviewing with Distinction
  • 2021/11 - 日本核医学会 症例検討会優秀賞
  • 2021/11 - 第8回日本核医学会リターニー賞
  • 2021/11 - 久田賞銀賞 Usefulness of gradient tree boosting for predicting histological subtype and EGFR mutation status of non-small cell lung cancer on 18F FDG-PET/CT.
  • 2021/05 - 最優秀発表賞
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page